Matinas BioPharma

Matinas BioPharma

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.17-$2.14
Market Cap
$2.8M
Shares Short
223,898

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
$0
Diluted EPS
-$1.15

News

See more

Yahoo Finance • last month

Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data

Yahoo Finance • last month

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

Yahoo Finance • 2 months ago

Matinas BioPharma faces NYSE notice over equity shortfall; gets until 2027 to comply

Yahoo Finance • 2 months ago

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

About

CEO
Mr. Jerome D. Jabbour J.D.
CFO
Mr. Jerome D. Jabbour J.D.
Address
1545 Route 206 South, Bedminster, NJ, United States, 07921
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
2